Suss Microtec Se · XETR:SMHN
Suss Microtec — Investor Day (November 2025)
22 slides from Suss Microtec's investor day presentation, November 2025
Slide 1: Financials (Dr. Cornelia Ballwießer)
Financials (Dr. Cornelia Ballwießer) Public | SUSS Capital Markets Day 2025 1
Slide 2: SUSS keeps moving: sales growth drivers
SUSS keeps moving Our 2030 ambitions and the associated strategies are the baseline for our mid-term financial planning Sales growth driver • Growth with our current portfolio, driven by attractive market growth in the addressable markets and market share gains • Establishing in new markets through
Slide 3: SUSS keeps moving: gross profit margin drivers
SUSS keeps moving Our 2030 ambitions and the associated strategies are the baseline for our mid-term financial planning Gross profit margin driver • Execution of the modularization and platform strategy • New products and innovations with above-average margins • Cost-optimized production network and
Slide 4: R&D spend and CapEx for future success of SUSS
R&D spend and R&D spend CapEx for future Focus on innovative solutions and follow-on success of SUSS product generations CapEx Supplying modern infrastructure to achieve long-term ambitions Public I SUSS Capital Markets Day 2025 4
Slide 5: R&D spending has been the main growth enabler, low average CapEx
R&D spending has been the main growth enabler at SUSS, while low average CapEx has led to a certain degree of underinvestment R&D spending and CapEx Cumulated amounts 2018 – 2025e 2018 – 2025 (in € m) New Zhubei production site: ~ €15m MicroOptics2 expansion 25.0 CapEx 75.2 in 2020/2021: 7.6 ⌀ CapEx
Slide 6: A steady increase in R&D spend will be necessary
To continue the growth path, a steady increase in R&D spend will be necessary in the coming years Cumulated amounts (R&D and CapEx) 460 – 500 Average annual CapEx level between 2026 and 2030 is likely to be between 100 – 120 + € 20 million and € 24 million, resulting to an average CapEx/sales ratio
Slide 7: The future success of SUSS will be evident in sales growth and margin improvement
The future Sales growth success of SUSS Between 2025 and 2030, we expect sales CAGR will be evident in of 9% to 13% particular through sales growth and Margin expansion margin By 2030, we will enter a improvement new gross profit and EBIT margin level for SUSS Public I SUSS Capital Markets Day 2025
Slide 8: 2025 sales target of €400 million already achieved in 2024
Thanks to strong sales growth, particularly in recent years, the 2025 sales target of €400 million was already achieved in 2024 Sales development CAGR 2023 – 2025e 2018 – 2025e 24.3 – 29.5% CAGR 2018 – 2023 (continued operations) 9.8% 39.1 21.5 25.7 22.6 446.1 470 – 510 13.1 304.3 230.6 237.7 260.0
Slide 9: Expected average sales growth of 9 to 13% between 2025 and 2030
Between 2025 and 2030, we expect average sales growth of 9 to 13%, with momentum picking up from 2027 onwards Sales development CAGR 2025e – 2030A1 2024 – 2025e – 2030A 9 – 13% +5.4 – 14.3% 750 – 900 • Sales growth expected from 2027 446.1 470 – 510 • 2026 is likely to be a transitional year with an
Slide 10: SUSS has significantly improved its margin profile since 2024
SUSS has significantly improved its margin profile since 2024, mainly due to its focus on semi-equipment business and large customers Gross profit and ⌀ GP margin 18 – 23 ⌀ GP margin 24 – 25: EBIT margin in % 33.8% ~38%2 2018 – 2025e 25 40.0% 40 20 35 – 37% 34.1% 16.8% 33.0% 35 15 11 – 13% 9.1% 30 1
Slide 11: Significant potential for further margin expansion
There is significant potential for further margin expansion, particularly driven by scheduled portfolio changes in our segments Gross profit and EBIT margin in % 43 – 45% 2024 – 2025e – 2030A GP margin ambition 45 30 + ~ 8%-points vs. 2025e 40.0% 40 25 35 – 37% 20 – 22% 35 EBIT margin ambition 20 +
Slide 12: EBIT margin to benefit from higher business volume
EBIT margin to benefit from higher business volume while increased R&D spend is covered by decline of SG&A expense ratio How to achieve the targeted EBIT margin of 20 – 22% Benefiting from increase Reduced SG&A expense in gross profit ratio projected Gross profit has the potential to • R&D expense r
Slide 13: Operating Cashflow and Free Cashflow expected to reach significantly higher levels in 2030
Based on our Cash flow generation strategic financial We plan to significantly improve Operating and model, Operating Free Cashflow in the coming years – with a significant Cashflow and Free improvement by the end of Cashflow are both the decade. expected to reach significantly higher levels in 2030
Slide 14: Operating and Free Cashflow have stabilized significantly
After strong fluctuations in 2019 and 2020, Operating and Free Cashflow have stabilized significantly Operating CF, CapEx and Free Cashflow 2018 – 2024 55.2 2024: Free Cashflow reached strong € 25.3 million after an average of € 13.2 million between 2021 and 2023. 32.6 24.3 21.1 11.3 12.5 6.9 9.6 7.
Slide 15: Significantly higher Operating CF and Free CF by end of decade
By the end of the decade, significantly higher levels of Operating CF and Free CF can be used to finance growth beyond 2030 2030: Operating CF (~ €100 million) and FCF (~ €90 million) could reach Operating CF, CapEx1 and Free Cashflow 2024 – 2030A significantly higher levels in 2030. However, this p
Slide 16: Generating shareholder value is a clear objective
Generating Shareholder return shareholder value It is our clear target to generate shareholder value, is a clear objective which is reflected in rising EPS and Free Cashflow per of our strategic share. In terms of capital plan for the period allocation, our primary goal remains to finance future up
Slide 17: Dividend policy
We have distributed dividends totaling €16.4 million to our shareholders for the years 2021 to 2024 Dividend distribution Dividend payments 2021 – 2024 2021 – 2024 (in € per share; payment in the following year) (in € million; payment in the following year) Dividend policy • Our shareholders should
Slide 18: Expected to generate significantly more value for shareholders by 2030
Based on our ambitions for 2030, we expect to generate significantly more value for our shareholders Earnings per share (in €) Our strategic growth plan envisages a significant improvement in earnings. This means that EPS could more than double by 2030. Free Cashflow per share (in €) Free cash flow
Slide 19: Maintaining sufficient liquidity to safeguard growth
We want to maintain sufficient liquidity to safeguard our targeted business growth and to buffer cash flow volatility Solid liquidity position We continue to consider a cash availability of ~ 25% of annual sales to be solid and typical for our industry Solid capital structure and high credit score •
Slide 20: Top priority for capital allocation is future investments
Our top priority for capital allocation is future investments that support targeted growth Invest to support targeted Maintain and further organic growth, strengthen balance sheet primarily through R&D spend to enable flexible funding and CapEx of growth-related activities Finance potential Our shar
Slide 21: Ambition to take SUSS to a new financial level by 2030
Our ambition is Sales FY 2024 €446.1 million FY 2030A €750 – 900 million to take SUSS to Sales growth 46.6% (YoY) 9 to 13% (CAGR 2025 – 2030A1) a new financial Gross profit margin (in %) 40% 43 to 45% level by 2030 SG&A (in % of sales) 13.8% ~11 to 12% R&D (in % of sales) 9.0% ~11% EBIT margin (in %
Slide 22: Disclaimer
Disclaimer The following presentations contain forward-looking statements relating to the business, financial performance and earnings of SUSS MicroTec SE and its subsidiaries and associates. Forward-looking statements are based on current plans, estimates, projections and expectations and are there